XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restatement of Previously Issued Financial Statements
9 Months Ended
Sep. 30, 2023
Prior Period Adjustment [Abstract]  
Restatement of Previously Issued Financial Statements
NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
In connection with the preparation of the financial statements of the Company as of and for the year ended
December
31, 2023, the Company determined that there were errors related to the (i) the failure to properly reflect as an expense the deferred consulting payments due to our chief financial officer if we complete our initial business combination (see Note 6), and (ii) the failure to record the capital contributions and related costs associated with the non-redemption agreements (see Note 6) in the previously issued financial statements as of and for the three and nine months ended September 30, 2023.
In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company determined that the errors were material to its previously issued financial statements. Therefore, the Company concluded that the previously issued financial statements should be restated.
The following tables summarize the effect of the restatement on each financial statement line items as of the dates, and for the period, indicated:
 
Balance sheet as of September 30, 2023
 
 
  
As previously reported
 
  
Adjustments
 
  
As revised 
 
Due to related party
  
$
146,138
 
  
$
187,200
 
  
$
333,338
 
Accrued tax payable - Income tax
  
 
252,567
 
  
 
27,776
 
  
 
280,343
 
Total current liabilities
     3,562,264        214,974        3,777,238  
Total liabilities
     13,257,264        214,974        13,472,238  
Class A common stock subject to redemption
     17,366,793        77,955        17,444,748  
Accumulated deficit
     (12,762,275      (292,929 )
 
     (13,055,204 )
 
Total stockholders’ deficit
     (12,761,700      (292,929 )      (13,054,629 )
 

Income statement for the three months ended
September
30, 2023
 
 
  
As previously reported
 
  
Adjustments
 
  
As revised 
 
Consulting Fees - CFO
  
 
— 
 
  
$
46,800
 
  
$
46,800
 
Total expenses
  
$
312,884
 
  
 
46,800
 
  
 
359,684
 
Net loss before income tax provision
  
 
(789,801
)
  
 
(46,800
)
 
  
 
(836,601
)
Income tax benefit
  
 
62,494
 
  
 
24,357
 
  
 
86,851
 
Net loss
  
 
(727,307
)
  
 
(22,443
)
  
 
(749,750
)
Basic and diluted net loss per share of Class A
common
stock
     (0.10      0.00        (0.10
Basic and diluted net loss per share of Class
B
 common stock
     (0.10      0.00        (0.10
 

Income statement for the nine months
ended
September 30, 2023
 
 
  
As previously reported
 
  
Adjustments
 
  
As revised 
 
Consulting fees - CFO
         
$
187,200     
$
187,200  
Non-redemption
agreement expense
  
 
 
  
 
180,000
 
  
 
180,000
 
Total expenses
  
$
1,345,682
 
  
 
367,200
 
  
 
1,712,882
 
Net income before income tax provision
  
 
3,340,259
 
  
 
(367,200
)
  
 
2,973,059
Income tax provision
     (917,501      (27,776      (945,277
Net income
     2,422,758        (394,976      2,027,782  
Basic and diluted net income per share of Class A common
 
stock
  
 
0.15
 
  
 
(0.03
)
  
 
0.12
 
Basic and diluted net income per share of Class 
B
 common
 
stock
  
 
0.15
 
  
 
(0.03
)
  
 
0.12